Stocktoria
biote Corp. BTMD
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-03-02
biote Corp. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 18.5% | 16.0% | 15.5% | -36.8% | 24.8% |
| Net margin | 14.1% | 1.6% | 1.8% | -0.6% | 8.0% |
| FCF margin | 15.7% | 19.7% | 14.3% | -5.8% | 23.2% |
| Return on assets | 25.1% | 2.6% | 2.1% | -0.9% | 20.5% |
| Return on equity | -46.2% | -3.0% | -9.1% | 1.7% | 269.4% |
| Debt / equity | -1.76× | -1.03× | -3.16× | -2.09× | 7.75× |
| Current ratio | 1.22 | 1.32 | 5.51 | 5.39 | 2.72 |
| Revenue growth | -2.5% | 6.4% | 12.4% | 18.3% | — |
Source: SEC EDGAR filings · CIK 0001819253 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.